{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-24-000230","form_type":"8-K","ticker":"ALDX","cik":"0001341235","company_name":"Aldeyra Therapeutics, Inc.","filed_at":"2024-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.874837+00:00","generated_at":"2026-06-06T03:13:14.646945+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Aldeyra Therapeutics presents at Oppenheimer Healthcare Conference; no material new financial data disclosed","bullets":["CEO Todd Brady participates virtually in fireside chat at Oppenheimer 34th Annual Healthcare Life Sciences Conference on Feb 13, 2024.","Discussion covers clinical and regulatory status of Aldeyra's product candidates for immune-mediated diseases.","Corporate presentation furnished as Exhibit 99.1; no earnings or financial guidance provided.","Filing is Regulation FD disclosure; presentation not incorporated by reference.","No specific milestones, data readouts, or financial results announced in the exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-24-000230","json":"https://secwatch.observer/filing/0001157523-24-000230.json","markdown":"https://secwatch.observer/filing/0001157523-24-000230.md","text":"https://secwatch.observer/filing/0001157523-24-000230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1341235/000115752324000230/0001157523-24-000230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1341235/000115752324000230/a53895165.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T03:13:14.646945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}